Study Stopped
Unable to complete full enrollment due to Covid pandemic.
Sensory Enrichment for Older Adults
1 other identifier
interventional
110
1 country
1
Brief Summary
This study evaluates the efficacy of multi-odorant enrichment on cognitive skills, olfactory function, and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 8, 2019
CompletedFirst Submitted
Initial submission to the registry
April 10, 2019
CompletedFirst Posted
Study publicly available on registry
April 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedMarch 24, 2023
February 1, 2023
2.3 years
April 10, 2019
March 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of behavioral pattern separation ability
Change in lure discrimination index on a computerized mnemonic discrimination task.
1) at Baseline and 2) after 6 months of intervention
Secondary Outcomes (6)
Evaluation of cognition
1) at Baseline and 2) after 6 months of intervention
Evaluation of depression
1) at Baseline and 2) after 6 months of intervention
Evaluation of quality of life
1) at Baseline and 2) after 6 months of intervention
Evaluation of olfactory function
1) at Baseline and 2) after 6 months of intervention
Evaluation of change in brain structural connectivity
1) at Baseline and 2) after 6 months of intervention
- +1 more secondary outcomes
Study Arms (2)
Experimental group
EXPERIMENTALIndividuals in this group receive exposure to a higher concentration of essential oil fragrances nightly.
Active control group
PLACEBO COMPARATORIndividuals in this group receive exposure to a lower concentration of essential oil fragrances nightly.
Interventions
Participants will be exposed to either a higher or lower concentration of essential oils nightly for two hours as they are going to sleep, using a nebulizing fragrance diffuser, rotating through seven different scents, one per night.
Eligibility Criteria
You may qualify if:
- Are age 60-85, male or female
- Have normal cognition (determined at first assessment with cognitive testing)
- Speak/read/understand English fluently
- Have visual and auditory acuity adequate for neuropsychological and computerized testing
- Are in good general health with no disease(s) expected to interfere with the study
- Are willing and able to participate for the duration of the study and in all study procedures
- Are able to smell scents
- Are willing to refrain from using scented candles, scented oils, or air fresheners while participating in the study
- Are willing to travel to the research site for testing
- If interested in functional Magnetic Resonance Imaging (fMRI),
- Are willing and able to participate in the fMRI scan.
You may not qualify if:
- Have known fragrance sensitivities
- Have asthma, allergies, or a fragrance sensitivity, which produces symptoms similar to those of an allergy, including runny nose, watery eyes, sneezing, or skin rash
- Have a neurologic disease such as Parkinson's disease, multiple sclerosis, brain cyst, tumor or aneurysm
- Have major health conditions such as uncontrolled diabetes mellitus, uncontrolled hypertension, nutritional deficiency or thyroid disease
- Have significant psychiatric disorders such as schizophrenia, bipolar disorder, anxiety disorder, or attention-deficit hyperactivity disorder
- Have cognitive impairment when tested at baseline (defined as a score on any neuropsychological test of 1.5 standard deviations or more outside the age norm)
- Have had alcohol or substance abuse or dependence within the past 2 years (DSM-IV criteria)
- Smoke cigarettes, e-cigarettes, cigars, marijuana, or any other substance that could produce an interfering odor for the study.
- If interested in functional Magnetic Resonance Imaging (fMRI),
- MRI contraindications, (e.g. pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin or body).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Irvinelead
- Procter and Gamblecollaborator
Study Sites (1)
University of California Irvine
Irvine, California, 92697, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Leon, PhD
University of California, Irvine
- PRINCIPAL INVESTIGATOR
Michael Yassa, PhD
University of California, Irvine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Both the participants and the assessors will be blinded to the group assignments.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 10, 2019
First Posted
April 16, 2019
Study Start
March 8, 2019
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
March 24, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share